Johnson & Johnson

NYSE: JNJ
$155.92
+$1.40 (+0.9%)
Real Time Data Delayed 15 Min.

JNJ Articles

Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.
thinkstockJanuary 15, 2015: Markets opened higher on Thursday following an announcement from the Swiss National Bank that it would no longer support the franc at €1.20. Oil prices shot up and...
Thursday's top analyst upgrades, downgrades include Apple, Barrick Gold, Corning, Groupon, Peabody Energy and SolarCity.
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical...
Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat.
thinkstockNovember 4, 2014: Markets opened slightly lower on Tuesday as the bottom fell out on crude oil which went on to finish the day down 2% at just above $77 a barrel. New 52-week highs were...
thinkstockOctober 14, 2014: Markets opened higher on Tuesday and had put up a nice gain by noon. Then the wheels came off and the major indexes drifted lower all afternoon as bargain hunting petered...
Johnson & Johnson reported better-than-expected third-quarter 2014 results before markets opened Tuesday.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 10, 2014.
thinkstockOctober 7, 2014: Markets opened lower on Tuesday and never even took a serious run at the break-even line. The JOLTS report on job openings posted a 13+-year high today, a good sign for...
The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.
The bull market may be five and a half years old, but stocks have been fighting each week to hit newer highs. These are the best- and worst-performing Dow stocks so far in 2014.